secwatch.observer — SEC 8-K summary
======================================

Issuer:     Ocean Biomedical, Inc. (OCEA)
CIK:        0001869974
Form:       8-K
Filed at:   2023-02-10T23:59:59+00:00
Accession:  0001493152-23-004252
Event type: m_and_a
Sentiment:  positive
Materiality: 0.75
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Aesther enters $60M backstop agreement with Vellar to support Ocean Biomedical merger
--------------------------------------------------------------------------------

- Vellar to purchase up to 6M AEHA shares in open market for up to $60M to backstop merger redemptions.
- Aesther will buy those shares on forward basis; prepayment equals redemption price per share.
- Backstop matures 3 years after closing or earlier if VWAP drops below $4 for 30 of 45 consecutive trading days.
- Vellar receives $12.408M from trust account for share consideration shares not subject to backstop.
- Break-up fee of $1M plus expenses payable to Vellar if business combination fails under certain conditions.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1869974/000149315223004252/0001493152-23-004252-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1869974/000149315223004252/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-23-004252

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer